Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	53.37	154.16	100.52
Graham Fair Price	-25.59	12.56	16.88
PEG	69.77	-1.48	-4.90
Price/Book	2.94	6.76	6.57
Price/Cash Flow	480.01	-470.46	81.11
Prices/Earnings	90.07	67.32	35.42
Price/Sales	16.99	28.93	24.73
Price/FCF	480.01	-470.46	81.11
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.15	0.56	0.57
Operating Margin	-31.19	0.13	0.19
ROA	-43.93	0.02	0.03
ROE	0.05	0.03	-45.84
ROIC	< 0.005	0.03	1551.53
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.21	-0.26	19.08
Dividends QOQ	< 0.005	0.09	35031.05
EBIT QOQ	-0.11	-0.39	-244.03
EPS QOQ	-0.07	-0.45	-528.79
FCF QOQ	0.46	-1.18	154.80
Revenue QOQ	-0.04	-0.11	-161.34
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	95.69	108.66	13.55
Days Sales Outstanding (DSO)	56.65	64.21	13.35
Inventory Turnover	0.94	0.83	-11.93
Debt/Capitalization	0.96	0.03	-96.74
Quick Ratio	1.88	2.13	13.39
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	16.53	16.71	1.11
Cash	5.36	4.89	-8.80
Capex	-0.29	-0.29	0.86
Free Cash Flow	1.34	-0.24	-82.05
Revenue	4.39	3.90	-11.03
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.28	3.75	14.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.26	-5.94	-39.39
Naive Interpretation	Member

06 - Financial Health · Bad

Rating